A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study)
Kinoshita et al., BMC Medicine, doi:10.1186/s12916-022-02518-7
https://c19early.org/kinoshita.html